Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02057393Completed
Open-label, single-arm trial of indocyanine green in melanoma, sponsored by Penn State Health Milton S. Hershey Medical Center. Primary endpoint: Equivalence of ICG and Real Time Lymphangiography to technetium99 and Blue Dye in Localizing Sentinel Nodes at 2 weeks. Started Jun 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02057393.